Creation of arteriovenous fistulae for hemodialysis in octogenarians

作者
Ewa Wątorek,Tomasz Gołębiowski,Mariusz Andrzej Kusztal,Krzysztof Letachowicz,Waldemar Letachowicz,Hanna Augustyniak‐Bartosik,Jerzy Stanisław Garcarek,Katarzyna Madziarska,Wacław Weyde,Marian Klinger
出处
期刊:Hemodialysis International [Wiley]
卷期号:18 (1): 113-117 被引量:18
标识
DOI:10.1111/hdi.12076
摘要

Elderly patients, defined as octogenarians and nonagenarians, are an increasing population entering renal replacement therapy. Advanced age appears as an exclusive factor negatively influencing dialysis practice. Elderly patients are referred late for the initiation of hemodialysis and more likely are offered catheters rather than arteriovenous fistulae (AVF), which increase mortality and negatively affect quality of life. We present our approach to the creation of vascular access for hemodialysis in this demanding population. In 2006-2012, 39 patients aged 85.9 ± 2.05 with end-stage renal disease, mainly resulting from ischemic nephropathy, were admitted to the Department of Nephrology to establish permanent vascular access for hemodialysis: preferably AVF. Temporary dialysis catheters were implanted in uremic emergency to bridge the time to fistula creation/maturation. AVF was attempted in 87.2% of the patients. Primary AVF function was achieved in 54% of the patients. Cumulative proportional survival of AVF at months 12 and 24 was 81.5%. Ninety-four percent of AVF were localized on the forearm: 74% in the distal and 20% in the proximal part. Mean duration of hemodialysis therapy was 20.80 ± 19.45 months. The mean time of AVF use was 15.9 ± 20.2 months. Until present, 38% have been dialyzed using AVF for 31.0 ± 18.8 months. Five patients died with functioning fistula. Eight patients initiated hemodialysis therapy with fistula. During further observation, the use of AVF increased to 62%. Elderly patients should not be denied creation of AVF as a rule. The outcome of AVF benefits more from acknowledging individual vascular conditions rather than age of the patient.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
紧张的道消完成签到 ,获得积分10
刚刚
刚刚
初景发布了新的文献求助10
刚刚
20030419ty2完成签到,获得积分10
刚刚
刚刚
lsx发布了新的文献求助10
刚刚
刚刚
屹男发布了新的文献求助10
刚刚
刚刚
米饭发布了新的文献求助10
1秒前
1秒前
今后的应助被科研通管家采纳,获得10
1秒前
桐桐的应助被科研通管家采纳,获得10
2秒前
orixero的应助被科研通管家采纳,获得10
2秒前
2秒前
桐桐的应助被科研通管家采纳,获得10
2秒前
Jun的应助被科研通管家采纳,获得20
2秒前
可爱的函函的应助被科研通管家采纳,获得200
2秒前
辽宁大学应用化学陈明完成签到 ,获得积分10
2秒前
彭于晏的应助被科研通管家采纳,获得10
2秒前
科研通AI65的应助被科研通管家采纳,获得10
2秒前
冻冻梨完成签到,获得积分10
2秒前
Orange的应助被科研通管家采纳,获得10
3秒前
英姑的应助被科研通管家采纳,获得10
3秒前
乐乐的应助被壮观梦易采纳,获得10
3秒前
null的应助被科研通管家采纳,获得10
3秒前
3秒前
DW的应助被科研通管家采纳,获得10
3秒前
风吹麦浪的应助被科研通管家采纳,获得10
3秒前
慕青的应助被科研通管家采纳,获得10
3秒前
汉堡包的应助被科研通管家采纳,获得10
3秒前
999发布了新的文献求助10
3秒前
Jun的应助被科研通管家采纳,获得20
4秒前
Hello的应助被科研通管家采纳,获得10
4秒前
顾矜的应助被科研通管家采纳,获得10
4秒前
NexusExplorer的应助被科研通管家采纳,获得10
4秒前
可爱的函函的应助被jj采纳,获得10
4秒前
null的应助被科研通管家采纳,获得10
4秒前
搜集达人的应助被科研通管家采纳,获得10
4秒前
秋风的应助被科研通管家采纳,获得20
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183739
求助须知:如何正确求助?哪些是违规求助? 9572996
关于积分的说明 21828615
捐赠科研通 7780904
什么是DOI,文献DOI怎么找? 3434101
关于科研通互助平台的介绍 2558294
邀请新用户注册赠送积分活动 2480564